semaglutide and celexa Lexapro: Insights into Effects and Interactions Semaxa

Unlike Ozempic/Wegovy, this is a dual agonist of GLP-1 and another intestinal peptide called GIP and trials point to greater efficacy in terms of weight loss, with a similar safety and tolerability profile

Despite all the enthusiasm surrounding GLP-1 agonist for obesity, it has been increasingly recognized that the profound weight loss is accompanied by substantial muscle loss accounting for up to as much as 40% of the weight loss, Regeneron CEO George Yancopoulos said during Fridays call with investors

The central clinical question was whether GLP-1 receptor agonist use around and after breast cancer diagnosis might be associated with lower all-cause mortality and improved recurrence-free survival

Thanks for the share